Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2025-64030
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Eximbills Enterprise 4.1.5 (Built on 2020-10-30) is vulnerable to authenticated stored cross-site scripting (CWE-79) via the /EximBillWeb/servlets/WSTrxManager endpoint. Unsanitized user input in the TMPL_INFO parameter is stored server-side and rendered to other users, enabling arbitrary JavaScript execution in their browsers.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
China Systems Eximbills Enterprise 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
China Systems Eximbills Enterprise是中国China Systems公司的一个贸易金融系统。 China Systems Eximbills Enterprise 4.1.5版本存在安全漏洞,该漏洞源于对TMPL_INFO参数未清理用户输入,可能导致存储型跨站脚本攻击。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2025-64030
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2025-64030
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2025-64030

No comments yet


Leave a comment